Twist Bioscience (TWST) Long-Term Investments (2021 - 2026)

Twist Bioscience has disclosed Long-Term Investments across 5 years of filings, most recently posting $68.1 million for Q1 2026.

• In Q1 2026, Long-Term Investments changed N/A year-over-year to $68.1 million; the TTM figure through Mar 2026 stood at $68.1 million (changed N/A YoY), while the FY2025 annual figure was $54.3 million, up 3463.08% from the prior year.
• Long-Term Investments grew to $68.1 million in Q1 2026, from $54.3 million in the prior quarter.
• Over the last five years, Long-Term Investments for TWST reached as high as $68.1 million in Q1 2026 and fell as low as $1.5 million in Q3 2024.
• The 4-year median for Long-Term Investments is $54.3 million (2025), against an average of $43.9 million.
• The widest YoY moves for Long-Term Investments: up 3463.08% in 2025, down 3463.08% in 2025.
• A 4-year view of Long-Term Investments shows it stood at $30.6 million in 2022, then tumbled by 95.01% to $1.5 million in 2024, then soared by 3463.08% to $54.3 million in 2025, then advanced by 25.31% to $68.1 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $68.1 million, $54.3 million, and $54.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.